MTACW (MedTech Acquisition) Long-Term Debt: $0.00 Mil (As of Jun. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MTACW MedTech Acquisition Corp MTACW
22 GF Score
Price $0.22
! 2 Warning Signs
View Full Analysis

What is MedTech Acquisition Long-Term Debt?

MedTech Acquisition MTACW +21.11% 22 Long-Term Debt is $0.00 Mil as of Jun. 2023. GuruFocus rates MTACW with a GF Score™ of 22/100. The stock has 2 warning signs investors should review.

MedTech Acquisition's Long-Term Debt for the quarter that ended in Jun. 2023 was $0.00 Mil.

MedTech Acquisition's quarterly Long-Term Debt declined from Dec. 2022 ($1.34 Mil) to Mar. 2023 ($0.00 Mil) but then stayed the same from Mar. 2023 ($0.00 Mil) to Jun. 2023 ($0.00 Mil).

MedTech Acquisition's annual Long-Term Debt increased from Dec. 2020 ($0.00 Mil) to Dec. 2021 ($0.54 Mil) and increased from Dec. 2021 ($0.54 Mil) to Dec. 2022 ($1.34 Mil).

MedTech Acquisition  (NAS:MTACW) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

MedTech Acquisition Long-Term Debt Related Terms

MedTech Acquisition Long-Term Debt Historical Data

* Premium members only.

The historical data trend for MedTech Acquisition's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedTech Acquisition Long-Term Debt Chart

MedTech Acquisition Annual Data
Trend Dec20 Dec21 Dec22
Long-Term Debt
0.00 0.54 1.34

MedTech Acquisition Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.50 0.70 1.34 0.00 0.00
MTACW
22GF Score
MedTech Acquisition Corp MTACW
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of $0.00 Mil mean?
MedTech Acquisition (MTACW) has a Long-Term Debt of $0.00 Mil as of Jun. 2023.
Is MedTech Acquisition's Long-Term Debt too high?
MedTech Acquisition's current Long-Term Debt is $0.00 Mil. Overall, MedTech Acquisition has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does MedTech Acquisition's Long-Term Debt compare to MON and HCII?
MedTech Acquisition's Long-Term Debt of $0.00 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Diversified Financial Services company?
A good Long-Term Debt depends on the Diversified Financial Services industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. MedTech Acquisition's current Long-Term Debt is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedTech Acquisition stock overvalued right now?
MedTech Acquisition (MTACW) has a current Long-Term Debt of $0.00 Mil. The current Long-Term Debt is $0.00 Mil. MedTech Acquisition's overall GF Score™ is 22/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For MedTech Acquisition (MTACW), the current Long-Term Debt is $0.00 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MedTech Acquisition Business Description

Address 48 Maple Avenue, Greenwich, CT, USA, 06830
MedTech Acquisition Corp is a blank check company.
22GF Score

Get the complete analysis for MTACW

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.22
Price